Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 176741, 6 pages
http://dx.doi.org/10.1155/2013/176741
Research Article

Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus

1Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran
2Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran
3Department of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran
4Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran

Received 25 August 2013; Accepted 17 September 2013

Academic Editors: A. La Cava and M. Pinti

Copyright © 2013 Bita Moudi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rahman and D. A. Iseberg, “Mechanisms of disease. Systemic lupus erythematosus,” The New England Journal of Medicine, vol. 358, pp. 929–939, 2008. View at Publisher · View at Google Scholar
  2. B. L. Kotzin, “Systemic lupus erythematosus,” Cell, vol. 85, no. 3, pp. 303–306, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Johnson, C. Gordon, R. G. Palmer, and P. A. Bacon, “The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: relationship to ethnicity and country of birth,” Arthritis and Rheumatism, vol. 38, no. 4, pp. 551–558, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Nath, J. Kilpatrick, and J. B. Harley, “Genetics of human systemic lupus erythematosus: the emerging picture,” Current Opinion in Immunology, vol. 16, no. 6, pp. 794–800, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. V. H. A. Rus and M. C. Hochberg, “Systemic lupus erythematosus,” in Epidemiology of the Rheumatic Diseases, A. J. H. M. Silman, Ed., pp. 123–140, Oxford University Press, 2nd edition, 2001. View at Google Scholar
  6. F. Andrade, L. Casciola-Rosen, and A. Rosen, “Apoptosis in systemic lupus erythematosus: clinical implications,” Rheumatic Disease Clinics of North America, vol. 26, no. 2, pp. 215–227, 2000. View at Google Scholar · View at Scopus
  7. L. E. Munoz, C. Van Bavel, S. Franz, J. Berden, M. Herrmann, and J. Van Der Vlag, “Apoptosis in the pathogenesis of systemic lupus erythematosus,” Lupus, vol. 17, no. 5, pp. 371–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Ren, J. Tang, M. Y. Mok, A. W. K. Chan, A. Wu, and C. S. Lau, “Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 48, no. 10, pp. 2888–2897, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. D. R. Green, “Overview: apoptotic signaling pathways in the immune system,” Immunological Reviews, vol. 193, pp. 5–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Nagata and T. Suda, “Fas and Fas ligand: lpr and gld mutations,” Immunology Today, vol. 16, no. 1, pp. 39–43, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Nagata, “Fas and Fas ligand: a death factor and its receptor,” Advances in Immunology, vol. 57, pp. 129–144, 1994. View at Google Scholar · View at Scopus
  12. T. Kamradt and N. A. Mitchison, “Tolerance and autoimmunity,” The New England Journal of Medicine, vol. 344, no. 9, pp. 655–664, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Behrmann, H. Walczak, and P. H. Krammer, “Structure of the human APO-1 gene,” European Journal of Immunology, vol. 24, no. 12, pp. 3057–3062, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Takahashi, M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata, “Human Fas ligand: gene structure, chromosomal location and species specificity,” International Immunology, vol. 6, no. 10, pp. 1567–1574, 1994. View at Google Scholar · View at Scopus
  15. M. Pinti, L. Troiano, M. Nasi et al., “Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians,” Cell Death and Differentiation, vol. 9, no. 4, pp. 431–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wu, C. Metz, X. Xu et al., “A novel polymorphic CAAT/enhancer-binding protein β element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients,” Journal of Immunology, vol. 170, no. 1, pp. 132–138, 2003. View at Google Scholar · View at Scopus
  17. N. Xiang, X. M. Li, G. S. Wang, J. H. Tao, and X. P. Li, “Association of FAS gene polymorphisms with systemic lupus erythematosus: a meta-analysis,” Molecular Biology Reports, vol. 40, no. 1, pp. 407–415, 2013. View at Publisher · View at Google Scholar
  18. Q. R. Huang, V. Danis, M. Lassere, J. Edmonds, and N. Manolios, “Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients,” Rheumatology, vol. 38, no. 7, pp. 645–651, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Sun, X. Miao, X. Zhang, W. Tan, P. Xiong, and D. Lin, “Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma,” Journal of the National Cancer Institute, vol. 96, no. 13, pp. 1030–1036, 2004. View at Google Scholar · View at Scopus
  20. P. A. Courtney, A. D. Crockard, K. Williamson, A. E. Irvine, R. J. Kennedy, and A. L. Bell, “Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia,” Annals of the Rheumatic Diseases, vol. 58, no. 5, pp. 309–314, 1999. View at Google Scholar · View at Scopus
  21. B. L. Liphaus and M. H. B. Kiss, “The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus,” Clinics, vol. 65, no. 3, pp. 327–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. R. De Maria and R. Testi, “Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity,” Immunology Today, vol. 19, no. 3, pp. 121–125, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. V. M. Budagyan, E. G. Bulanova, N. I. Sharova, M. F. Nikonova, M. L. Stanislav, and A. A. Yarylin, “The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells,” Immunology Letters, vol. 60, no. 1, pp. 1–5, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Fukuyama, M. Adachi, S. Suematsu et al., “Requirement of FAS expression in B cells for tolerance induction,” European Journal of Immunology, vol. 32, pp. 223–230, 2002. View at Publisher · View at Google Scholar
  25. T. Takahashi, M. Tanaka, C. I. Brannan et al., “Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand,” Cell, vol. 76, no. 6, pp. 969–976, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Kovacs, S.-N. C. Liossis, G. J. Dennis, and G. C. Tsokos, “Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus,” Autoimmunity, vol. 25, no. 4, pp. 213–221, 1997. View at Google Scholar · View at Scopus
  27. N. Suzuki and T. Sakane, “Abnormal Fas and Fas ligand expression of lymphocytes in patients with SLE,” Nippon Rinsho: Japanese Journal of Clinical Medicine, vol. 54, no. 7, pp. 1955–1959, 1996. View at Google Scholar · View at Scopus
  28. J. Wu, J. Wilson, J. He, L. Xiang, P. H. Schur, and J. D. Mountz, “Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease,” Journal of Clinical Investigation, vol. 98, no. 5, pp. 1107–1113, 1996. View at Google Scholar · View at Scopus
  29. Q. R. Huang, D. Morris, and N. Manolios, “Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene,” Molecular Immunology, vol. 34, no. 8-9, pp. 577–582, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. H. Lee, Y. R. Kim, J. D. Ji, J. Sohn, and G. G. Song, “Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus,” Journal of Rheumatology, vol. 28, no. 9, pp. 2008–2011, 2001. View at Google Scholar · View at Scopus
  31. S. Kanemitsu, K. Ihara, A. Saifddin et al., “A functional polymorphism in Fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus,” Journal of Rheumatology, vol. 29, no. 6, pp. 1183–1188, 2002. View at Google Scholar · View at Scopus
  32. J. M. Araste, E. K. Sarvestani, E. Aflaki, and Z. Amirghofran, “Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules,” Immunological Investigations, vol. 39, no. 1, pp. 27–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-Y. Chen, C.-M. Wang, C.-C. Ma, Y.-H. Chow, and S.-F. Luo, “The −844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE,” Genes and Immunity, vol. 6, no. 2, pp. 123–128, 2005. View at Publisher · View at Google Scholar · View at Scopus